These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7780345)
1. [Basic characteristics of macrophage as an effector cell]. Voĭtenkov BO; Okulov VB Vestn Ross Akad Med Nauk; 1995; (4):59-64. PubMed ID: 7780345 [No Abstract] [Full Text] [Related]
2. Macrophage Activation Mechanisms in Human Monocytic Cell Line-derived Macrophages. Sumiya Y; Ishikawa M; Inoue T; Inui T; Kuchiike D; Kubo K; Uto Y; Nishikata T Anticancer Res; 2015 Aug; 35(8):4447-51. PubMed ID: 26168485 [TBL] [Abstract][Full Text] [Related]
3. Liposome-encapsulated macrophage activation agents and active non-specific immunotherapy of neoplastic disease. Poste G; Kirsh R Prog Clin Biol Res; 1982; 102 pt A():309-19. PubMed ID: 7167443 [No Abstract] [Full Text] [Related]
4. Macrophages and metastasis--a biological approach to cancer therapy. Fidler IJ Cancer Res; 1985 Oct; 45(10):4714-26. PubMed ID: 2992766 [No Abstract] [Full Text] [Related]
5. The functions of the macrophage in malignant disease. Alexander P Annu Rev Med; 1976; 27():207-24. PubMed ID: 779596 [No Abstract] [Full Text] [Related]
6. Eradication of cancer metastasis by tumoricidal macrophages. Fidler IJ Adv Exp Med Biol; 1988; 233():415-23. PubMed ID: 3223395 [No Abstract] [Full Text] [Related]
7. Marshaling macrophages against metastases. Zoler ML JAMA; 1983 Apr; 249(13):1690-1, 1695. PubMed ID: 6600797 [No Abstract] [Full Text] [Related]
8. Regulatory T cells in cancer immunotherapy. Nishikawa H; Sakaguchi S Curr Opin Immunol; 2014 Apr; 27():1-7. PubMed ID: 24413387 [TBL] [Abstract][Full Text] [Related]
9. Macrophages and antitumor reactions. Den Otter W; Dullens HF; De Weger RA Cancer Immunol Immunother; 1983; 16(2):67-71. PubMed ID: 6362848 [No Abstract] [Full Text] [Related]
11. The suppressor-cell network in cancer (second of two parts). Broder S; Waldmann TA N Engl J Med; 1978 Dec; 299(24):1335-41. PubMed ID: 362202 [No Abstract] [Full Text] [Related]
12. The generation of tumoricidal activity in macrophages for the treatment of established metastases. Fidler IJ Symp Fundam Cancer Res; 1983; 36():421-35. PubMed ID: 6382518 [No Abstract] [Full Text] [Related]
14. [Effect of immune processes on the growth and regression of malignant tumors]. Russo V; Russo L Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500 [No Abstract] [Full Text] [Related]
15. Macrophages in primary and secondary tumor growth: some implications for cancer therapy. Keller R Biomed Pharmacother; 1985; 39(1):7-12. PubMed ID: 3875370 [TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity. Spreafico F; Mantovani A Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217 [No Abstract] [Full Text] [Related]
17. Macrophages in cancer and infectious diseases: the 'good' and the 'bad'. Porta C; Riboldi E; Totaro MG; Strauss L; Sica A; Mantovani A Immunotherapy; 2011 Oct; 3(10):1185-202. PubMed ID: 21995571 [TBL] [Abstract][Full Text] [Related]